SenesTech, Inc. — Form 8-K
Filed October 15, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 72/100
What the filing says
SenesTech reported preliminary Q3 2026 revenue of $1.1 million, representing 40% sequential growth from Q2 2026 and 55% year-over-year growth from Q3 2025. This is the company's first quarter exceeding $1 million in revenue and marks its highest quarterly revenue in company history. Management attributes growth to e-commerce scaling, B2B traction, and expanding subscription revenue.
Why this rating
Revenue milestone is 5.7% of $19.2M market cap; strong growth trajectory meaningful for micro-cap biotech. Preliminary results; execution risk remains.
Tradability signal
NO TRADE
No trade: the filing reads positive but the market is selling it (-4.1% since it hit EDGAR) — when our read and the tape disagree this hard, we stand aside. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
before filing · preread $0.68 ▲ 5.51% | at our read · unknown $0.64 | +10 min · unknown $0.69 ▲ 7.12% | +30 min · unknown $0.73 ▲ 13.72% | +1 hr · unknown $0.71 ▲ 10.96% | +4 hrs · unknown $0.76 ▲ 18.33% |
The stock had already moved -5.22% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.